NEWS
HACKENSACK MERIDIAN HEALTH PARTNERS WITH NEOSOMA FOR INNOVATION IN BRAIN TUMOUR TREATMENT
Hackensack Meridian Health and Neosoma , an innovative medical technology company focused on helping clinicians advance the treatment of brain cancers through the use of Artificial Intelligence ( AI ), have announced a new strategic partnership to tackle some of the most difficult-to-treat tumours . The collaboration will include clinical data sharing , clinical research and strategic investment from the health network to support the Massachusetts-based company ' s innovative method of imaging , tracking and collecting data on numerous types of brain tumours including glioblastomas .
" We are committed to investing in research and innovative therapies to live our mission to transform healthcare and give our patients the best possible outcomes ,'' said Robert C .
Garrett , FACHE , CEO , Hackensack Meridian Health . " Partnering with Neosoma is a great way to continue to develop potential game-changing therapies to treat these challenging cancers ."
" We have a terrific partnership with Hackensack Meridian Health already ," said Ken Kolodziej , CEO and Co-founder of Neosoma . " We ' re very excited to expand the scope of our collaboration with the shared goal of improving treatment and outcomes for patients with brain cancer ."
The partnership will include HMH physicians using Neosoma ' s software in clinical practice , starting with Hackensack Meridian JFK University Medical Center ; physician input and feedback for the development of future software including neurosurgeons , neuro-oncologists , neuroradiologists , radiation oncologists and other clinicians ; and data sharing for product R & D efforts including collaboration with Anthology Diagnostics for genomics data and capabilities , among other benefits .
STUDY FINDS THAT CONSUMERS PREFER TELEHEALTH TO IN-PERSON VISITS WHILE TRAVELLING
Nearly 68 % of consumers who needed minor medical services while travelling last year received care via telehealth with their regular physicians or affiliated members of their physicians ' care teams , outpacing all other care-delivery options . These findings come from a new survey sponsored by KeyCare .
" The results of this survey confirm that there is substantial consumer demand for telehealth services while travelling , but just as importantly , reveal a strong patient preference for virtual visits with telehealth providers who are closely connected to their main health system ," said Lyle Berkowitz , MD , CEO of KeyCare .
" With KeyCare , health systems have access to a virtual care workforce that uses Epic ' s EHR platform , allowing us to more directly integrate with the majority of health systems in the United States .” �
For consumers who received telehealth care while travelling , speed and convenience ( 52 %) were the top factors influencing their decisions , followed by the ability to receive care from their regular care team ( 27 %) and cost ( 19 %).
Respondents reported receiving services from one or more care delivery options . Sixty-eight percent received care via telehealth from their regular physicians or affiliated care team members ; 33 % from a locally based urgent care clinic ; 30 % via telehealth from a provider not affiliated with their regular doctors ; and 18 % from an emergency room .
12
www . intelligenthealth . tech